{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:29:17Z","timestamp":1787146157679,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Fund","award":["82200794"],"award-info":[{"award-number":["82200794"]}]},{"name":"National Natural Science Fund","award":["82090020"],"award-info":[{"award-number":["82090020"]}]},{"name":"National Natural Science Fund","award":["82270754"],"award-info":[{"award-number":["82270754"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05162-y","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:14:34Z","timestamp":1782764074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the ratio of non-HDL-cholesterol to HDL-cholesterol with clinical and pathological characteristics in diabetic kidney disease"],"prefix":"10.1186","volume":"27","author":[{"given":"Liang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"5162_CR1","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864\u201383.","journal-title":"Diabetes Care"},{"key":"5162_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","volume":"107","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107:689\u2013705.","journal-title":"Med Clin North Am"},{"key":"5162_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815\u201322.","journal-title":"Lancet"},{"issue":"2","key":"5162_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2019.05.032","volume":"76","author":"C Yang","year":"2020","unstructured":"Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258\u201364.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5162_CR5","doi-asserted-by":"publisher","first-page":"e15450","DOI":"10.1111\/dme.15450","volume":"42","author":"I Dasgupta","year":"2025","unstructured":"Dasgupta I, Zac-Varghese S, Chaudhry K, et al. Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines. Diabet Med. 2025;42(2):e15450.","journal-title":"Diabet Med"},{"key":"5162_CR6","doi-asserted-by":"publisher","first-page":"1503711","DOI":"10.3389\/fendo.2025.1503711","volume":"16","author":"QM Tu","year":"2025","unstructured":"Tu QM, Jin HM, Yang XH. Lipid abnormality in diabetic kidney disease and potential treatment advancements. Front Endocrinol (Lausanne). 2025;16:1503711.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5162_CR7","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/ijms21072632","volume":"21","author":"L Opazo-R\u00edos","year":"2020","unstructured":"Opazo-R\u00edos L, Mas S, Mar\u00edn-Royo G, et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. 2020;21:2632.","journal-title":"Int J Mol Sci"},{"key":"5162_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19:629\u201345.","journal-title":"Nat Rev Nephrol"},{"key":"5162_CR9","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.2337\/dc16-1246","volume":"39","author":"GT Russo","year":"2016","unstructured":"Russo GT, De Cosmo S, Viazzi F, et al. Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD Annals Initiative. Diabetes Care. 2016;39:2278\u201387.","journal-title":"Diabetes Care"},{"key":"5162_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.1523-1755.2003.00164.x","volume":"64","author":"AJ Jenkins","year":"2003","unstructured":"Jenkins AJ, Lyons TJ, Zheng D, et al. Lipoproteins in the DCCT\/EDIC cohort: associations with diabetic nephropathy. Kidney Int. 2003;64:817\u201328.","journal-title":"Kidney Int"},{"key":"5162_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12944-024-02308-5","volume":"23","author":"J Pan","year":"2024","unstructured":"Pan J, Li C, Zhang J, et al. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with diabetes in the United States: a cross-sectional study. Lipids Health Dis. 2024;23:317.","journal-title":"Lipids Health Dis"},{"key":"5162_CR12","doi-asserted-by":"publisher","first-page":"1509752","DOI":"10.3389\/fendo.2025.1509752","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Xu H. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular disease mortality in patients with type 2 diabetes mellitus and diabetic kidney disease. Front Endocrinol (Lausanne). 2025;16:1509752.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5162_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jad.2023.10.064","volume":"344","author":"X Qi","year":"2024","unstructured":"Qi X, Wang S, Huang Q, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of depression among US adults: a cross-sectional NHANES study. J Affect Disord. 2024;344:451\u20137.","journal-title":"J Affect Disord"},{"key":"5162_CR14","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1016\/j.ijcard.2013.03.027","volume":"168","author":"SW Kim","year":"2013","unstructured":"Kim SW, Jee JH, Kim HJ, et al. Non-HDL-cholesterol\/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B\/apolipoprotein A1. Int J Cardiol. 2013;168:2678\u201383.","journal-title":"Int J Cardiol"},{"key":"5162_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12944-024-02012-4","volume":"23","author":"G Qing","year":"2024","unstructured":"Qing G, Deng W, Zhou Y, Zheng L, Wang Y, Wei B. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and suicidal ideation in adults: a population-based study in the United States. Lipids Health Dis. 2024;23:17.","journal-title":"Lipids Health Dis"},{"key":"5162_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12944-020-01336-1","volume":"19","author":"WS Yang","year":"2020","unstructured":"Yang WS, Li R, Shen YQ, et al. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Lipids Health Dis. 2020;19:160.","journal-title":"Lipids Health Dis"},{"key":"5162_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12916-024-03536-3","volume":"22","author":"B Yu","year":"2024","unstructured":"Yu B, Li M, Yu Z, et al. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999\u20132018. BMC Med. 2024;22:317.","journal-title":"BMC Med"},{"key":"5162_CR18","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/DMSO.S355980","volume":"15","author":"G Sheng","year":"2022","unstructured":"Sheng G, Liu D, Kuang M, Zhong Y, Zhang S, Zou Y. Utility of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in evaluating incident diabetes risk. Diabetes Metab Syndr Obes. 2022;15:1677\u201386.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5162_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13098-025-01637-4","volume":"17","author":"S Wen","year":"2025","unstructured":"Wen S, Li J, Xie Z, Chen X, Li J, Lin X. The role of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (nhhr) in prediabetes progression and the mediating effect of BMI: a longitudinal study in China. Diabetol Metab Syndr. 2025;17:67.","journal-title":"Diabetol Metab Syndr"},{"key":"5162_CR20","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.3760\/cma.j.issn.0366-6999.20132906","volume":"127","author":"B Gao","year":"2014","unstructured":"Gao B, Zhang L, Wang H, Zhao M. Chinese cohort study of chronic kidney disease: design and methods. Chin Med J (Engl). 2014;127:2180\u20135.","journal-title":"Chin Med J (Engl)"},{"key":"5162_CR21","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2024;47:S20\u2013S42.","DOI":"10.2337\/dc24-S002"},{"key":"5162_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361\u201377.","journal-title":"Nat Rev Nephrol"},{"key":"5162_CR23","doi-asserted-by":"publisher","first-page":"1398793","DOI":"10.3389\/fphys.2024.1398793","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Guo J. Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hypertension in American adults: a NHANES cross-sectional study. Front Physiol. 2024;15:1398793.","journal-title":"Front Physiol"},{"key":"5162_CR24","doi-asserted-by":"publisher","first-page":"1430835","DOI":"10.3389\/fnut.2024.1430835","volume":"11","author":"W Xie","year":"2024","unstructured":"Xie W, Liu H, Lin Q, Lian L, Liang B. Association of non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) with prognosis in cancer survivors: a population-based study in the United States. Front Nutr. 2024;11:1430835.","journal-title":"Front Nutr"},{"key":"5162_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12944-025-02536-3","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Li L, Tang Y, et al. Changes in non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) and cardiovascular disease: insights from CHARLS. Lipids Health Dis. 2025;24:112.","journal-title":"Lipids Health Dis"},{"key":"5162_CR26","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382.","journal-title":"Lancet"},{"key":"5162_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11906-024-01314-3","volume":"26","author":"R Siddiqui","year":"2024","unstructured":"Siddiqui R, Obi Y, Dossabhoy NR, Shafi T. Is there a role for sglt2 inhibitors in patients with end-stage kidney disease? Curr Hypertens Rep. 2024;26:463\u201374.","journal-title":"Curr Hypertens Rep"},{"key":"5162_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"5162_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","volume":"91","author":"S Sethi","year":"2017","unstructured":"Sethi S, D\u2019Agati VD, Nast CC, et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int. 2017;91:787\u20139.","journal-title":"Kidney Int"},{"key":"5162_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/ndt\/gfw417","volume":"33","author":"K Furuichi","year":"2018","unstructured":"Furuichi K, Yuzawa Y, Shimizu M, et al. Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transpl. 2018;33:138\u201348.","journal-title":"Nephrol Dial Transpl"},{"key":"5162_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","volume":"129","author":"FM Sacks","year":"2014","unstructured":"Sacks FM, Hermans MP, Fioretto P, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation. 2014;129:999\u20131008.","journal-title":"Circulation"},{"key":"5162_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/nu17071125","volume":"17","author":"X Chen","year":"2025","unstructured":"Chen X, Liang M, Zhang J, et al. The non-high-density lipoprotein cholesterol (non-HDL-C) to HDL-C ratio (NHHR) and its association with chronic kidney disease in Chinese adults with type 2 diabetes: a preliminary study. Nutrients. 2025;17:1125.","journal-title":"Nutrients"},{"key":"5162_CR33","doi-asserted-by":"publisher","first-page":"155377","DOI":"10.1016\/j.metabol.2022.155377","volume":"139","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wu Y, Zhang J, et al. ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease. Metabolism. 2023;139:155377.","journal-title":"Metabolism"},{"key":"5162_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2023;8:152.","journal-title":"Signal Transduct Target Ther"},{"key":"5162_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018;14:57\u201370.","journal-title":"Nat Rev Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05162-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:09:00Z","timestamp":1787144940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05162-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5162"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05162-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The investigation was conducted in accordance with the Declaration of Helsinki and received approval from the Institutional Review Board of Peking University First Hospital. The C-STRIDE cohort study was approved under approval number 2011[363], and the use of EMR data was approved under approval number 2017\u2009\u2212\u20091280. The biological sample donors signed informed consent forms, agreeing that the donated samples and related information could be used for all medical research. Given the retrospective, observational design of this analysis, which used only anonymized clinical data without any intervention or re-contact with patients, the Institutional Review Board of Peking University First Hospital granted a waiver of informed consent and conducted a new ethics review specifically for this study, with approval number 2025R0541.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"492"}}